| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Crispr Therapeutics AG (CRSP) has 7 insiders with recent SEC Form 4 filings, including 13 buys and 0 sells. CRSP is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 255.5K | $13.89M | - | |
| Dir | 22.0K | $1.20M | - | |
| CFO | 19.5K | $1.06M | - | |
| Other | 19.4K | $1.05M | -3,786 | |
| Other | 17.0K | $924.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 24, 2016 | Lundberg Sven Ante | Chief Scientific Officer | Buy | 400 | $14.00 | $5,600.00 | - | |
| Oct 24, 2016 | Glaxosmithkline Plc | 10% Owner | Buy | 66,500 | $14.00 | $931,000.00 | +2.1% | |
| Oct 24, 2016 | George Simeon | Director | Buy | 66,500 | $14.00 | $931,000.00 | +2.1% | |
| Oct 24, 2016 | Celgene Corp /de/ | 10% Owner | Buy | 800,150 | $14.00 | $11,202,100.00 | +19.8% | |
| Oct 24, 2016 | Emster Kurt Von62 | Director | Buy | 56,000 | $14.00 | $784,000.00 | +2.2% | |
| Oct 24, 2016 | Woiwode Thomas | Director | Buy | 161,000 | $14.00 | $2,254,000.00 | +2.4% | |
| Oct 24, 2016 | Bolzon Bradley J Phd75 | Director | Buy | 161,000 | $14.00 | $2,254,000.00 | +2.4% |